Cyclacel pharmaceuticals announces amendment to exchange agreement

Kuala lumpur, malaysia, july 07, 2025 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; “cyclacel” or the “company”), a biopharmaceutical company developing innovative medicines, today announced that it has entered into an amendment to the exchange agreement with fitters diversified berhad (9318.kl; “fitters”), an investment holding company engaged, through its subsidiaries, in the business of the sale of fire safety materials, equipment and fire prevention systems, “waste-to-resource” services and real estate development and construction.
CYCC Ratings Summary
CYCC Quant Ranking